Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Eur J Cancer

Retrieve available abstracts of 9 articles:
HTML format

Single Articles

    May 2022
  1. MIFSUD W, Furtwangler R, Vokuhl C, D'Hooghe E, et al
    Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies.
    Eur J Cancer. 2022;166:1-7.
    PubMed     Abstract available

    March 2022
  2. ALIFRANGIS C, Sharma A, Chowdhury S, Duncan S, et al
    Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
    Eur J Cancer. 2022;164:105-113.
    PubMed     Abstract available

    October 2021
  3. MALUF FC, Schutz FA, Cronemberger EH, Luz MA, et al
    A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).
    Eur J Cancer. 2021;158:63-71.
    PubMed     Abstract available

  4. VOLDERS ELD, Gietema JA, van Beek AP, Emous M, et al
    Bariatric surgery in a testicular cancer survivor: Restoring both metabolic and testosterone status.
    Eur J Cancer. 2021;158:12-14.

    September 2021
  5. HOVEN E, Fagerkvist K, Jahnukainen K, Ljungman L, et al
    Sexual dysfunction in young adult survivors of childhood cancer - A population-based study.
    Eur J Cancer. 2021;154:147-156.
    PubMed     Abstract available

    August 2021
  6. HIESTER A, Fingerhut A, Niegisch G, Siener R, et al
    Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection - A 13-year follow-up analysis of a
    Eur J Cancer. 2021;155:64-72.
    PubMed     Abstract available

    July 2021
  7. SALZMANN M, Tosev G, Heck M, Schadendorf D, et al
    Male fertility during and after immune checkpoint inhibitor therapy: A cross-sectional pilot study.
    Eur J Cancer. 2021;152:41-48.
    PubMed     Abstract available

    February 2021
  8. ANDERSON RA, Clatot F, Demeestere I, Lambertini M, et al
    Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessments.
    Eur J Cancer. 2021;144:310-316.
    PubMed     Abstract available

    March 2020
  9. GILBERT A, Drinkwater K, McParland L, Adams R, et al
    UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes.
    Eur J Cancer. 2020;128:7-16.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.